ESC 365 - Role of sumoylation modification of sirtuin 3 in hypertension-associated

ESC Professional Premium Access

Role of sumoylation modification of sirtuin 3 in hypertension-associated

Session: Hypertension: biomarkers, genetics, and molecular mechanisms

Topic: Prevention

Speaker: Doctor S. Runmin (Lanzhou, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Sun Runmin

Lanzhou (China)

0 follower

5 more presentations in this session

Relationship between fibrosis-4 index and new onset hypertension in the general population

Speaker: Doctor H. Takase (Hamamatsu, JP)

Conditional over-expression of heme-oxygenase 1 in myelomonocytic cells reduces AngII-induced hypertension and vascular inflammation in mice

Speaker: Professor P. Wenzel (Mainz, DE)

The role of IL15 in angiotensin II-mediated cardiac remodelling

Speaker: Ms E. Booth (Glasgow, GB)

Exercise-induced inflammatory and thrombotic acute phase response in hypertensive patients.

Speaker: Doctor C. Liakos (Athens, GR)

Blood pressure polygenic risk scores associate with resistant hypertension in individuals with type 1 diabetes

Speaker: Doctor H. Sanez Tahtisalo (Helsinki, FI)

Access the full session

Hypertension: biomarkers, genetics, and molecular mechanisms

Speakers: Doctor S. Runmin, Doctor H. Takase, Professor P. Wenzel, Ms E. Booth, Doctor C. Liakos...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources